Navigation Links
Endo Pharmaceuticals Announces Receipt of Paragraph IV Certification
Date:1/31/2011

's periodic reports filed with the Securities and Exchange Commission, including current reports on Form 8-K, quarterly reports on Form 10-Q and annual reports on Form 10-K, particularly the discussion under the caption "RISK FACTORS" in our periodic and current reports filed with the Securities and Exchange Commission. The forward-looking statements in this press release are qualified by these risk factors. These are factors that, individually or in the aggregate, could cause our actual results to differ materially from expected and historical results. We assume no obligation to publicly update any forward-looking statements, whether as a result of new information, future developments or otherwise.


'/>"/>
SOURCE Endo Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... , Sept. 30, 2014  Georgia-Pacific Professional ... towels and tissue for a wide range of ... of its product lines in healthcare, including hospitals, ... Georgia-Pacific Professional is introducing its healthcare products and ... Professional understands the importance of infection control in ...
(Date:9/30/2014)... 2014 In a recent study ... backflow of the Eldor spinal needle 25G, 103 mm ... pencil point spinal needles of the same gauge and ... anesthesia is an excellent type of regional anesthesia for ... etc. It is estimated that 100 million ...
(Date:9/30/2014)... ST. PAUL, Minn. , Sept. 30, 2014 /PRNewswire/ ... the United States abused prescription pain ... dependence include detoxification or maintenance treatment, which entails the ... and costs of these treatments are important when developing ... studies by pharmacy benefit manager Prime Therapeutics ...
Breaking Medicine Technology:Georgia-Pacific Professional Brings Its Success in Medical Solutions to the Dental Community 2Georgia-Pacific Professional Brings Its Success in Medical Solutions to the Dental Community 3Studies show cost and use of opioid dependence treatment are increasing, spurring the need for care management programs 2Studies show cost and use of opioid dependence treatment are increasing, spurring the need for care management programs 3
... (Nasdaq: ARAY ), the premier radiation oncology ... present at the Oppenheimer Healthcare Conference in New York ... EST/10:00 a.m. PST.  A live webcast ... Investor Relations page of the Company,s website at ...
... Foundation for Infectious Diseases (NFID) joins the Centers for ... of influenza prevention during National Influenza Vaccination Week, December ... holiday season and beyond. Influenza vaccination rates ... years, but many parents remain unaware that annual vaccination ...
Cached Medicine Technology:National Foundation for Infectious Diseases Supports 2011 National Influenza Vaccination Week 2National Foundation for Infectious Diseases Supports 2011 National Influenza Vaccination Week 3National Foundation for Infectious Diseases Supports 2011 National Influenza Vaccination Week 4
(Date:9/30/2014)... 30, 2014 Speaking on this occasion, ... observed ‘Nursing Conference’ as a remarkable event, which brings ... medical and clinical research and diagnostic companies, leading universities ... a perfect platform to share experience, foster collaborations across ... world. Nursing Conference is a forum to explore issues ...
(Date:9/30/2014)... New Zealand (PRWEB) September 30, 2014 ... the potential to improve breast cancer risk prediction ... according to a study published in Breast Cancer ... “Digital mammographic density and breast cancer risk: a ... demonstrates a strong connection between breast density and ...
(Date:9/30/2014)... and its partners successfully established a visual mapping ... myeloid derived suppressor cells (MDSC). The damage and ... understood, however this is a major stepping stone ... by tumor-derived factors from precursors present in hematopoietic ... spleen. This population of cells suppresses the activity ...
(Date:9/30/2014)... A recent study completed at the University of Eastern ... the risk of coronary heart disease. The sources of ... The findings were published in Arteriosclerosis, Thrombosis & ... Heart Association. , Recent studies have not found an ... risk of cardiovascular diseases. It seems that the mere ...
(Date:9/30/2014)... 2014 This two-day, advanced PT ... sequellae that may arise following a concussion or ... can be varied, from sports related injuries, car accidents, ... by the thousands of returning soldiers from war zone ... and blunt traumas can result in similar injuries, the ...
Breaking Medicine News(10 mins):Health News:Exploring New Possibilities to Take Nursing Profession to Great Heights 2Health News:Exploring New Possibilities to Take Nursing Profession to Great Heights 3Health News:Mammographic Density Offers Potential to Improve Prediction of Breast Cancer Risk and Development of Personalized Screening 2Health News:Mammographic Density Offers Potential to Improve Prediction of Breast Cancer Risk and Development of Personalized Screening 3Health News:Mammographic Density Offers Potential to Improve Prediction of Breast Cancer Risk and Development of Personalized Screening 4Health News:Dietary polyunsaturated fatty acids linked to smaller risk of coronary heart disease 2Health News:North American Seminars Presents Traumatic Brain Injury and Concussions in Conduction with St. Anthony's Medical Center in St. Louis, MO on November 8-9, 2014 2Health News:North American Seminars Presents Traumatic Brain Injury and Concussions in Conduction with St. Anthony's Medical Center in St. Louis, MO on November 8-9, 2014 3
... Minn. People with a particular gene variant may be more ... people without the gene, according to a study published in the ... journal of the American Academy of Neurology. , The ... no cancers. All those with tumors had glioblastoma multiforme, the most ...
... when they spend any timeeven a few monthswithout health care ... 2009 issue of Medical Care Research and Review . ... four months, there is a 2.8 percentage point decrease in ... the study, Partial-Year Insurance Coverage and the Health Care Utilization ...
... other experts sponsor workshop to investigate increase in Acanthamoeba ... contact lens care products and protect against infectionsST. LOUIS, ... safety and effectiveness of contact lenses and lens care ... Optometric Association (AOA) co-sponsored a workshop last week with ...
... of batches tested positive, third of popular sweetened products ... Almost half of tested samples of commercial high-fructose corn ... nearly a third of 55 popular brand-name food and ... labeled ingredient, according to two new U.S. studies. , ...
... AFL ) announced today that it will release ... 2, 2009. , In conjunction ... meeting on Tuesday, February 3, 2009. During the ... discuss Aflac,s fourth,quarter and year-end results. Following Mr. Amos, ...
... of cases, study finds , , MONDAY, Jan. 26 ... the United States are more likely than girls ... at football, soccer, volleyball, basketball, wrestling, baseball and ... 8 percent of all injuries suffered by high ...
Cached Medicine News:Health News:New study: Short coverage lapses limit children's access to health care services 2Health News:AOA Doctors of Optometry Partner With FDA and Other Industry Leaders to Develop New Measures to Better Protect Contact Lens Wearers 2Health News:AOA Doctors of Optometry Partner With FDA and Other Industry Leaders to Develop New Measures to Better Protect Contact Lens Wearers 3Health News:AOA Doctors of Optometry Partner With FDA and Other Industry Leaders to Develop New Measures to Better Protect Contact Lens Wearers 4Health News:AOA Doctors of Optometry Partner With FDA and Other Industry Leaders to Develop New Measures to Better Protect Contact Lens Wearers 5Health News:Study Finds High-Fructose Corn Syrup Contains Mercury 2Health News:Aflac Incorporated To Release Fourth Quarter Results on February 2, 2009 2Health News:HS Sports Shoulder Injuries More Likely in Boys 2
This adjustable-volume digital micropipet is used to accurately measure and transfer small solution volumes in the 20-200 microliter range....
... and density. Proven ergonomic design reduces hand fatigue, prevents injury. Dry seal ... 20-200 ... 1.0~2.0 Imprecision(%) ... 1 Dimensions: ...
This CLS number is a new product number, created to easily match Cornings product number. If showing no availability yet, please order under the old Sigma-Aldrich number (Z71,411-9) or contact custom...
Pipetman P is a fully adjustable, air-displacement pipette with the selected volume shown on a digital indicator (volumeter). Eight models cover the full range of volumes from 0.2 L to 10 mL....
Medicine Products: